Top Markets
Coin of the day
Pharma Mar, S.A. Pharma Mar, S.A.

Pharma Mar, S.A.

PHM
Rankning i aktier #7111
Pharma Mar, S.A., a biopharmaceutical firm established in 1986 and... Pharma Mar, S.A., a biopharmaceutical firm established in 1986 and headquartered in Madrid, Spain, is dedicated to the research, development, production, and global sale of marine-derived bioactive compounds. Its primary focus is oncology, with operations spanning Spain, Italy, Germany, Ireland, the wider European Union, the United States, and other international markets. The company's activities are organized into three key segments: Oncology, Diagnostics, and RNA interference. Among its developed and commercialized treatments are Yondelis, prescribed for soft tissue sarcomas and ovarian cancer; Aplidin, targeting multiple myeloma; and Zepzelca, used for patients with small cell lung cancer. Furthermore, Pharma Mar is advancing PM14, currently in Phase II clinical trials for various solid tumors. Beyond pharmaceuticals, the company manufactures and markets diagnostic kits and is involved in creating therapeutic drugs designed to reduce or silence gene expression.
Aktiekurs
$99.16
Senast synkroniserad: 2026-08-27
Marknadsvärde
$1.72B
Förändring (1 dag)
0.00%
Förändring (1 år)
2.52%
Land
ES
Handel Pharma Mar, S.A. (PHM)

Kategori

Historik för aktiesplit för Pharma Mar, S.A. (PHM)
Aktien Pharma Mar, S.A. (symbol: PHM) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 28, 2026.
En PHM-aktie köpt före Aug 28, 2026 motsvarar nu 0 PHM-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH